The Royal Marsden experience of small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil
Open Access
- 1 August 1998
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (4) , 508-510
- https://doi.org/10.1038/bjc.1998.523
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.Journal of Clinical Oncology, 1997
- Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survivalCancer, 1996
- Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenumInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Adenocarcinoma of the duodenum: Factors influencing survivalBritish Journal of Surgery, 1994
- Improving resectability and survival in patients with primary duodenal carcinomaThe American Journal of Surgery, 1993
- Primary adenocarcinoma of duodenal bulb benefitted by chemotherapyDigestive Diseases and Sciences, 1991
- Chemotherapy for primary adenocarcinoma of the small bowelCancer, 1984
- Adenocarcinoma of the small intestineThe American Journal of Surgery, 1984
- Reporting results of cancer treatmentCancer, 1981
- Carcinoma of the duodenum: Comparison of surgery, radiotherapy, and chemotherapyBritish Journal of Surgery, 1973